Progress has been made in using the Gleason score, the PSA and the clinical tumor stage to separate prostate cancers into three groups; low risk, intermediate risk and high risk tumors. This video explains the differences and how the information can be used to select the right treatment.
Link to this comment:
All Comments (0)